These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21898709)

  • 1. Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment.
    Salisbury AL; Wisner KL; Pearlstein T; Battle CL; Stroud L; Lester BM
    Depress Anxiety; 2011 Nov; 28(11):1008-19. PubMed ID: 21898709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes.
    Santucci AK; Singer LT; Wisniewski SR; Luther JF; Eng HF; Dills JL; Sit DK; Hanusa BH; Wisner KL
    J Clin Psychiatry; 2014 Oct; 75(10):1088-95. PubMed ID: 25373117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.
    Moses-Kolko EL; Bogen D; Perel J; Bregar A; Uhl K; Levin B; Wisner KL
    JAMA; 2005 May; 293(19):2372-83. PubMed ID: 15900008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
    Salisbury AL; O'Grady KE; Battle CL; Wisner KL; Anderson GM; Stroud LR; Miller-Loncar CL; Young ME; Lester BM
    Am J Psychiatry; 2016 Feb; 173(2):147-57. PubMed ID: 26514656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors.
    Smith MV; Sung A; Shah B; Mayes L; Klein DS; Yonkers KA
    Early Hum Dev; 2013 Feb; 89(2):81-6. PubMed ID: 22999988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications.
    Oberlander TF; Bonaguro RJ; Misri S; Papsdorf M; Ross CJ; Simpson EM
    Mol Psychiatry; 2008 Jan; 13(1):65-73. PubMed ID: 17519929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior.
    Zeskind PS; Stephens LE
    Pediatrics; 2004 Feb; 113(2):368-75. PubMed ID: 14754951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study.
    Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
    Br J Psychiatry; 2008 May; 192(5):338-43. PubMed ID: 18450656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are maternal depression or symptom severity associated with breastfeeding intention or outcomes?
    Bogen DL; Hanusa BH; Moses-Kolko E; Wisner KL
    J Clin Psychiatry; 2010 Aug; 71(8):1069-78. PubMed ID: 20584521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine Motor Differences and Prenatal Serotonin Reuptake Inhibitors Exposure.
    Partridge MC; Salisbury AL; LaGasse LL
    J Pediatr; 2016 Aug; 175():144-149.e1. PubMed ID: 27215778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy.
    Singer LT; Moore DG; Fulton S; Goodwin J; Turner JJ; Min MO; Parrott AC
    Neurotoxicol Teratol; 2012; 34(3):303-10. PubMed ID: 22387807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infants following prenatal antidepressant exposure.
    Suri R; Hellemann G; Stowe ZN; Cohen LS; Aquino A; Altshuler LL
    J Clin Psychiatry; 2011 Jul; 72(7):1002-7. PubMed ID: 21672498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.
    Yang A; Ciolino JD; Pinheiro E; Rasmussen-Torvik LJ; Sit DKY; Wisner KL
    J Clin Psychiatry; 2017 May; 78(5):605-611. PubMed ID: 28570796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mother-infant antidepressant concentrations, maternal depression, and perinatal events.
    Sit D; Perel JM; Wisniewski SR; Helsel JC; Luther JF; Wisner KL
    J Clin Psychiatry; 2011 Jul; 72(7):994-1001. PubMed ID: 21824458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors.
    Bakhireva LN; Sparks A; Herman M; Hund L; Ashley M; Salisbury A
    Pediatr Res; 2022 Mar; 91(4):867-873. PubMed ID: 34588611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major depressive disorder during pregnancy: Psychiatric medications have minimal effects on the fetus and infant yet development is compromised.
    Gustafsson HC; Goodman SH; Feng T; Choi J; Lee S; Newport DJ; Knight B; Pingeton B; Stowe ZN; Monk C
    Dev Psychopathol; 2018 Aug; 30(3):773-785. PubMed ID: 30068426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.
    Oberlander TF; Grunau RE; Fitzgerald C; Papsdorf M; Rurak D; Riggs W
    Pediatrics; 2005 Feb; 115(2):411-25. PubMed ID: 15687451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and maternal mood on mother-infant interactions at 3 months of age.
    Weikum WM; Mayes LC; Grunau RE; Brain U; Oberlander TF
    Infant Behav Dev; 2013 Dec; 36(4):485-93. PubMed ID: 23728194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect.
    Hanley GE; Brain U; Oberlander TF
    Early Hum Dev; 2013 Aug; 89(8):519-24. PubMed ID: 23384962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
    Casper RC; Gilles AA; Fleisher BE; Baran J; Enns G; Lazzeroni LC
    Psychopharmacology (Berl); 2011 Sep; 217(2):211-9. PubMed ID: 21499702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.